FORMER UFC heavyweight champion Brock Lesnar has been officially sidelined for one year but will be eligible to return to action as early as July 2017.
Lesnar has received a one-year suspension from the United States Anti-Doping Agency after he tested positive for a banned substances on two different occasions surrounding his fight at UFC 200 against Mark Hunt.
He was given the maximum ban under the UFC's anti-doping policy, given the substance in question.
"Lesnar, 39, tested positive for clomiphene and its metabolite, 4-hydroxyclomiphene, following an out-of-competition urine test conducted on June 28, 2016, and an in-competition urine test conducted on July 9, 2016, at UFC 200 in Las Vegas,” a USADA statement released yesterday said.
"Clomiphene is a prohibited substance in the category of hormone and metabolic modulators and is prohibited at all times under the UFC Anti-Doping Policy, which has adopted the WADA Prohibited List.
"Lesnar's one-year period of ineligibility began on July 15, 2016, the date on which he was provisionally suspended by USADA, and is identical in length to the sanction imposed by the Nevada State Athletic Commission on December 15, 2016.
"In addition, the NSAC overturned Lesnar's victory at UFC 200 to a no-contest.”
In December, Lesnar was suspended for one year by the NSAC and also fined $250,000 for the infraction.
USADA ultimately matched that suspension with Lesnar's date of ineligibility beginning on July 15, 2016, which means the former heavyweight champion would be able to return to fighting as early as July 15, 2017, if he decides to compete again.
Lesnar has made no clear indication on whether he will take another fight in the UFC or just continue his career with the WWE, where he currently performs as a professional wrestler.
Unless he officially retires during the ban, he is required to remain in USADA's drug testing pool. Should he retire, the ban is frozen and still applicable should he announce a comeback, while he would also need to re-enter the drug testing pool.
Update your news preferences and get the latest news delivered to your inbox.